CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TME Pharma NV is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TME Pharma NV
Max-Dohrn-Str. 8-10
Phone: +49 307262470p:+49 307262470 BERLIN, 10589  Germany Ticker: ALTMEALTME
Business Summary
TME Pharma NV formerly NOXXON Pharma NV is a biotechnology company focusing on developing therapies for the treatment of cancers. The Company specializes in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Its technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. their clinical programs in glioblastoma and pancreatic cancer have delivered results and further development is planned.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Supervisory Board MaurizioPetitBon 76 1/1/2023 9/1/2016
Chief Executive Officer, Member of the Management Board AramMangasarian 53 7/1/2015
Independent Deputy Chairperson of the Supervisory Board SusanColes 58 6/29/2023 6/24/2021
Independent Member of the Supervisory Board Cornelis A.Izeboud 53 6/30/2020 6/30/2020
Member of the Supervisory Board AlexandraGlucksmann 65 9/30/2024 9/30/2024

Business Names
Business Name
0N6
0N6A
ALNOX
ALTME
NOXXON Pharma AG

General Information
Number of Employees: 13 (As of 12/31/2023)
Outstanding Shares: 17,284,838 (As of 12/31/2023)
Stock Exchange: EPA
Fax Number: +49 30726247225


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025